跳至主要内容
临床试验/NCT03455673
NCT03455673已完成不适用

Diagnostic Accuracy of the ATE Score for the Exclusion of Intra-atrial Thrombi Before Catheter Ablation of Atrial Fibrillation: a Confirmatory Study

Groupe Hospitalier de la Rochelle Ré Aunis15 个研究点 分布在 2 个国家目标入组 3,160 人开始时间: 2018年9月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3,160
试验地点
15
主要终点
Number of Patients With Atrial Thrombus and a Zero ATE Score

研究概览

简要总结

Atrial fibrillation is the most frequent heart rhythm disorder. Its symptomatic forms, resistant to drug therapy, require invasive management (catheter ablation), which exposes to potentially serious complications including thromboembolic complications. Despite anticoagulant treatment, intra-atrial thrombus, which is a contraindication to catheter ablation, is detected in nearly 2 % of cases. Its diagnosis requires prior transoesophageal echocardiography, an unpleasant examination.

A previous study (NCT02199080) showed that a zero ATE score, defined by no heart failure, no hypertension, no history of stroke, d-dimer < 270 ng/mL, has a negative predictive value of 100 % for the exclusion of intra-atrial thrombus.

The objective of the study is to confirm the negative predictive value, sensitivity and specificity of the ATE score for the exclusion of intra-atrial thrombus.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients,
  • Patients hospitalized for ablation of atrial fibrillation or symptomatic left atrial tachycardia,
  • have signed or orally given an informed consent

排除标准

  • Contraindication to transoesophageal echocardiography,
  • Transoesophageal echocardiography made in another centre than the centre of ablation,
  • Pregnant women, parturient mothers and nursing mothers,
  • Lives in an institution on court or authority order,
  • Severely altered psychological health,
  • Persons leaving in health or social establishment,
  • Under guardianship,
  • Persons unable to give their consent,
  • Refusal to participate in the study.

研究组 & 干预措施

Atrial fibrillation

ATE score will be determined for patients hospitalized for ablation of atrial fibrillation or symptomatic left atrial tachycardia

干预措施: ATE score (Diagnostic Test)

结局指标

主要结局

Number of Patients With Atrial Thrombus and a Zero ATE Score

时间窗: at most 48 hours before ablation

Patients with atrial thrombus diagnosed by pre-procedural transoesophageal echocardiography, without hypertension, heart failure, history of stroke and a plasma d-dimer level \< 270 ng/ml ATE : Atrial Thrombus Exclusion minimum value = 0 maximum value = 4, patient at higher risk of atrial thrombus

次要结局

  • Number of Patients With Atrial Thrombus(at most 48 hours before ablation)
  • Number of Patients With Atrial Thrombus Among Patients With a Zero CHADS2 Score(at most 48 hours before ablation)
  • Number of Patients With Atrial Thrombus Among Patients With a Zero CHADS2VASC Score(at most 48 hours before ablation)

研究者

发起方
Groupe Hospitalier de la Rochelle Ré Aunis
申办方类型
Other
责任方
Sponsor

研究点 (15)

Loading locations...

相似试验